Pharma Fine

SAN FRANCISCO – Shareholders brought a federal derivative lawsuit against McKesson Corp. and its top executives and directors for the $150 million settlement with the Drug Enforcement Administration announced two weeks ago, for violations of the Controlled Substances Act.